Lotus Pharmaceutical
TWSE:1795 Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
AN
Consensus Narrative from 5 Analysts
Alpha Choay Acquisition And New R&D Center Will Strengthen Southeast Asia Presence
Key Takeaways Strategic acquisitions and alliances are bolstering Lotus Pharmaceutical's growth and diversification, particularly in Southeast Asia. In-house production and a strong product pipeline are enhancing profitability and driving revenue and earnings growth.
View narrativeNT$371.80
FV
32.2% undervalued intrinsic discount7.03%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Updated narrative